Evidence map›Paper›PMID 39382062›Full record

ArticleAnnals of clinical and translational neurology2024

CHA

Yukihiro Imaoka, Nice Ren, Soshiro Ogata, Hirotoshi Imamura, Yasuyuki Kaku, Koichi Arimura, Shogo Watanabe, Eri Kiyoshige, Kunihiro Nishimura, Syoji Kobashi and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of clinical and translational neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yukihiro Imaoka *Department of Stroke and Cardiovascular Disease Next Generation Medical Research, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID 0000-0002-7054-2708
Nice Ren *Department of Stroke and Cardiovascular Disease Next Generation Medical Research, National Cerebral and Cardiovascular Center, Osaka, Japan.
Soshiro Ogata *Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Hirotoshi ImamuraDepartment of Neurosurgery, National Cerebral and Cardiovascular Center, Osaka, Japan.
Yasuyuki KakuDepartment of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Koichi ArimuraDeparment of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Shogo WatanabeDepartment of Stroke and Cardiovascular Disease Next Generation Medical Research, National Cerebral and Cardiovascular Center, Osaka, Japan.
Eri KiyoshigeDepartment of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kunihiro NishimuraDepartment of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
Syoji KobashiDepartment of Stroke and Cardiovascular Disease Next Generation Medical Research, National Cerebral and Cardiovascular Center, Osaka, Japan.
Masafumi IharaDepartment of Neurology, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID 0000-0002-7102-4048
Kenji KamiyamaDepartment of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Hokkaido, Japan.
Masafumi MorimotoDepartment of Neurosurgery, Yokohama Shintoshi Neurosurgery Hospital, Yokohama, Kanagawa, Japan.
Tsuyoshi OhtaDepartment of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Hidenori EndoDepartment of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Yuji MatsumaruDeparment of Neurosurgery, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Nobuyuki SakaiDepartment of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Takanari KitazonoDeparment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Shigeru FujimotoDivision of Neurology, Department of Medicine, Jichi Medical University, Tochigi, Japan.
Kuniaki OgasawaraDeparment of Neurosurgery, Iwate Medical University, Morioka, Iwate, Japan.
Koji IiharaDepartment of Stroke and Cardiovascular Disease Next Generation Medical Research, National Cerebral and Cardiovascular Center, Osaka, Japan.
Close The Gap‐Stroke, J‐ASPECT Study Collaborators

Funding

Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center 20-4-10Japan Agency for Medical Research and Development JP19ek0210088Japan Agency for Medical Research and Development JP20ek0210129Japan Agency for Medical Research and Development JP20ek0210147Japan Agency for Medical Research and Development JP21ek0210147Japan Agency for Medical Research and Development JP22ek0210147Japan Society for the Promotion of Science 18H02914Japan Society for the Promotion of Science 22H03191Japan Society for the Promotion of Science 23K24450Japan Society for the Promotion of Science 25293314the Japanese Ministry of Health, Labour and Welfare 19AC1003the Japanese Ministry of Health, Labour and Welfare 21FA1010the Japanese Ministry of Health, Labour and Welfare 22FA1015the Japanese Ministry of Health, Labour and Welfare 23FA1014the Japanese Ministry of Health, Labour and Welfare 24FA1015the Japanese Ministry of Health, Labour and Welfare 24FA1016the Japanese Ministry of Health, Labour and Welfare H28-Shinkin-Ippan-011
6 · The paper itself

Abstract

objectiveWe evaluated the effect of CHA

methodsPatients with AF who received EVT in 353 centers in Japan (2018-2020) were included. The outcomes were symptomatic intracerebral hemorrhage (sICH), in-hospital mortality, functional independence, and successful and complete reperfusion. The effects of CHA

resultsOf the 6984 patients, 780 (11.2%) used warfarin and 1168 (16.7%) used direct oral anticoagulants (DOACs) before EVT. Based on the CHA

interpretationPrior DOAC use for patients with high- and selected intermediate-risk CHA

Indexed as

AnticoagulantsAtrial FibrillationEndovascular ProceduresIschemic StrokeAdministration, OralAgedAged, 80 and overFemaleHospital MortalityHumansJapanMaleMiddle AgedRisk AssessmentWarfarinAnticoagulantsWarfarin

Identifiers

PMID39382062
PMCPMC11651198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.